The amino azanoradamantane hexahydro-2,5b-methano-1H-3aS, 3aa,6aa-cycl
openta-[c]pyrrole-4a-amine 1 and the corresponding enantiomer ent-1 ha
ve been prepared along with benzamide derivatives SC-52491 and SC-5249
0, respectively, which are of pharmaceutical interest. The key meso-az
abicyclo[3.3.0] intermediate 3 was prepared via three separate routes:
a [3+2] cycloaddition route, a radical cyclization/ionic cyclization
route, and a reductive Pauson-Khand route. Copyright (C) 1996 Elsevier
Science Ltd